Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia-Reference-Cited by-同舟云学术

Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia

Published:2021-01-01 Issue:2 Volume:52 Page:601-609
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Marashi-Sabouni Zeina,Vayne Caroline,Ibrahim-Kosta Manal,Guidon Catherine,Loundou Anderson,Guery Eve Anne,Morange Pierre-Emmanuel,Camoin-Jau Laurence^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-020-02349-4.pdf

Reference39 articles.

1. Arepally GM (2017) Heparin-induced thrombocytopenia. Blood 129:2864–2872

2. Cuker A (2014) Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost 40:106–114

3. Cuker A (2011) Heparin-induced thrombocytopenia: present and future. J Thromb Thrombolysis 31:353–366. https://doi.org/10.1007/s11239-011-0569-6

4. Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K et al (2010) The HIT expert probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 8:2642–2650

5. Althaus K, Hron G, Strobel U, Abbate R, Rogolino A, Davidson S et al (2013) Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia. Thromb Res 131:e85-90

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review;Research and Practice in Thrombosis and Haemostasis;2023-10

2. Optimization of laboratory diagnosis of heparin-induced thrombocytopenia using HemosIL-AcuStar-HIT-IgG assay;Laboratory Medicine;2023-04-24

3. Anti-PF4 (heparin-independent)/PF4 complex induces allosteric activation of integrins αIIbβ3 and αvβ3, a potential mechanism of vaccine-induced thrombotic thrombocytopenia (VITT) and autoimmune diseases;2022-08-18

4. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia;Pathology;2022-04

5. Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS;Antibodies;2022-01-21